- Home
- ELUT
ELUT
Elutia Inc.
as 04-18-2025 1:35pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | SILVER SPRING |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | $9.00 | AVG Volume (30 days): | 44.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.87 - $5.24 | Next Earning Date: | 05-08-2025 |
| Revenue: | $24,375,000 | Revenue Growth: | -1.50% |
| Revenue Growth (this year): | 39.35% | Revenue Growth (next year): | 61.26% |
Stock Insider Trading Activity of Elutia Inc. (ELUT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HighCape Capital, L.P. | ELUT | Director10% Owner | Feb 3 '25 | Buy | $2.50 | 840,000 | $2,100,000.00 | 9,520,232 |
Latest Elutia Inc. News
ELUT Breaking Stock News: Dive into ELUT Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
Elutia Confirms No Material Impact from Global Tariffs
GlobeNewswire
15 days ago
EluPro™ Named as 2025 Edison Award Winner
GlobeNewswire
16 days ago
Elutia to Participate in Upcoming Investor Conferences
GlobeNewswire
17 days ago
Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
GlobeNewswire
23 days ago
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™
GlobeNewswire
25 days ago
Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope
GlobeNewswire
a month ago
Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out
GuruFocus.com
a month ago
Earnings To Watch: Elutia Inc (ELUT) Reports Q4 2024 Result
Compare ELUT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ELUT Elutia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.